Enanta Pharmaceuticals, Inc. (ENTA) quarterly cash flow statement — complete operating, investing & financing history
Enanta Pharmaceuticals, Inc. (ENTA) cash flow statement — 15-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -9.97M | -7.16M | -11.7M | -6.49M | 17.51M | -13.49M | -16.8M | -10.4M | -14.78M | -28.6M | -24.99M | -21.6M | -32.13M | -13.78M | -35.64M | -15.53M | -29.6M | -26.38M | -13.27M | -21.02M |
| Operating CF Margin % | -69.45% | -41.7% | -62.85% | -42.9% | 95.59% | -90.37% | -99.07% | -71.2% | -82.22% | -167.71% | -138.8% | -114.1% | -170.06% | -77.45% | -151.12% | -76.46% | -151.97% | -140.92% | -48% | -89.17% |
| Operating CF Growth % | -156.96% | 46.95% | 30.37% | 37.61% | 218.48% | 52.84% | 32.76% | 51.86% | 54.01% | -107.51% | 29.89% | -39.06% | -8.53% | 47.74% | -168.56% | 26.1% | -0.33% | -476% | 10.87% | -35.96% |
| Net Income | -19.5M | -13.09M | -11.94M | -18.7M | -18.25M | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.06M | -37.66M | -28.99M | -26.35M | -31.7M | -33.59M | -30.11M | -24.6M |
| Depreciation & Amortization | 1.19M | 1.21M | 1.25M | 1.28M | 1.21M | 1.2M | 889K | 479K | 594K | 621K | 642K | 669K | 651K | 540K | 511K | 655K | 716K | 822K | 780K | 806K |
| Stock-Based Compensation | 3.68M | 3.75M | 3.81M | 4.03M | 4.18M | 4.69M | 5.67M | 7.72M | 5.42M | 5.56M | 8.1M | 6.72M | 7M | 7.36M | 7.14M | 6.83M | 7.6M | 6.47M | 6.06M | 5.35M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 546K | 345K |
| Other Non-Cash Items | 2.14M | 1.03M | -1.94M | 1.51M | -1.93M | 1.16M | -1.18M | 1.06M | -823K | -279K | 1.06M | -7.09M | 519K | -1.04M | -339K | -30K | 146K | 54K | -474K | -71K |
| Working Capital Changes | 2.52M | -49K | -2.88M | 5.38M | 32.3M | 2.11M | 113K | 9.16M | 2.69M | -3.35M | -1.38M | 6.21M | -1.23M | 17.01M | -13.97M | 3.36M | -6.37M | -130K | 9.93M | -2.85M |
| Change in Receivables | 1.27M | 665K | -1.61M | 1.48M | 32.27M | -466K | -1.52M | 1.99M | -844K | 120K | -289K | 5.19M | 1.76M | 4.79M | -2.27M | -839K | -763K | 8.93M | -4.07M | -1.95M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -287.33M |
| Change in Payables | -1.08M | 2.48M | -63K | -723K | -1.29M | 873K | -168K | -1.54M | 863K | -4.91M | 5.17M | -3.83M | -3.28M | 6.65M | -686K | 3.92M | -5.08M | -1.81M | -1.66M | 3.58M |
| Cash from Investing | 14.01M | 11.94M | -47.3M | 2.3M | -26.48M | -4.37M | 68.9M | 19.07M | -6.34M | 58.62M | -13.12M | 11.84M | -145.75M | 46.77M | 33.57M | 28.23M | 16.22M | -35.05M | 45.5M | 72.68M |
| Capital Expenditures | -7K | -15K | -143K | -1.46M | -155K | -2.54M | -8.74M | -8.95M | -6.54M | -1.67M | -787K | -1.37M | -2.15M | -2.38M | -3.16M | -1.44M | -251K | -74K | -363K | -33K |
| CapEx % of Revenue | 0.05% | 0.09% | 0.77% | 9.64% | 0.85% | 17% | 51.57% | 61.28% | 36.4% | 9.78% | 4.37% | 7.23% | 11.39% | 13.39% | 13.38% | 7.07% | 1.29% | 0.4% | 1.31% | 0.14% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.33M | 0 | 0 | -49.15M | -36.73M | -29.67M | -16.47M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.33M | 0 | 0 | 49.15M | 36.73M | 29.67M | 16.47M | 0 | 0 | 0 |
| Cash from Financing | -5.54M | -7.29M | 64.14M | -8.32M | -6.42M | -6.89M | -4.99M | -7.21M | -6.65M | -6.41M | -7.35M | -23K | 199.88M | -2.03M | 301K | 2.93M | 4.12M | 3.35M | 9.63M | 943K |
| Debt Issued (Net) | 0 | 0 | -5.86M | -26.49M | 0 | 0 | -4.94M | -7.26M | 0 | 0 | -7.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 492K | 49K | 70.09M | 51K | -94K | 0 | 94K | 68K | 28K | 51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -6.03M | -7.34M | -97K | 18.11M | -6.33M | -6.89M | -137K | -19K | -6.67M | -6.46M | -183K | -23K | 199.88M | -2.03M | 301K | 2.93M | 4.12M | 3.35M | 9.63M | 943K |
| Net Change in Cash | -1.51M | -2.51M | 5.14M | -12.51M | -15.4M | -24.74M | 47.12M | 1.46M | -27.77M | 23.61M | -45.45M | -9.79M | 22M | 30.95M | -1.77M | 15.63M | -9.26M | -58.08M | 41.86M | 52.6M |
| Free Cash Flow | -9.98M | -7.17M | -11.84M | -7.95M | 17.35M | -16.03M | -25.55M | -19.35M | -21.32M | -30.27M | -25.77M | -22.97M | -34.28M | -16.17M | -38.8M | -16.97M | -29.85M | -26.45M | -13.63M | -21.05M |
| FCF Margin % | -69.5% | -41.79% | -63.62% | -52.54% | 94.74% | -107.37% | -150.63% | -132.48% | -118.62% | -177.49% | -143.17% | -121.33% | -181.45% | -90.85% | -164.5% | -83.53% | -153.26% | -141.32% | -49.31% | -89.31% |
| FCF Growth % | -157.51% | 55.25% | 53.64% | 58.93% | 181.4% | 47.05% | 0.89% | 15.76% | 37.81% | -87.24% | 33.56% | -35.35% | -14.83% | 38.88% | -184.56% | 19.39% | 0.17% | -461.67% | 9.58% | -33.33% |
| FCF per Share | -0.34 | -0.25 | -0.41 | -0.37 | 0.81 | -0.75 | -1.20 | -0.91 | -1.01 | -1.43 | -1.22 | -1.09 | -1.63 | -0.77 | -1.86 | -0.82 | -1.44 | -1.29 | -0.67 | -1.04 |
| FCF Conversion (FCF/Net Income) | 0.51x | 0.55x | 0.98x | 0.35x | -0.96x | 0.60x | 0.75x | 0.36x | 0.65x | 0.92x | 0.75x | 0.77x | 0.82x | 0.37x | 1.23x | 0.59x | 0.93x | 0.79x | 0.44x | 0.85x |
| Interest Paid | -5.45M | 0 | 0 | 1.61M | 1.71M | 0 | 0 | 2.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |